Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06236113 · ClinicalTrials.gov registry record · Phase 4

Low Dose Ketamine for Blunt Thoracic Trauma

A Phase 4 study of Blunt Injury of Thorax and Multiple Rib Fractures, Involving Three Ribs, sponsored by North Memorial Health Care.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target
1
Study location

NCT06236113 is a Phase 4 study of Blunt Injury of Thorax and Multiple Rib Fractures, Involving Three Ribs that has completed, run by North Memorial Health Care. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06236113, a Phase 4 study of Blunt Injury of Thorax and Multiple Rib Fractures, Involving Three Ribs, has completed, sponsored by North Memorial Health Care.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this Randomized controlled double-blinded trial is to compare the addition of a ketamine infusion to placebo, when added to standard care in adult blunt trauma patients with multiple rib fractures. The main question it aims to answer are: • addition of low dose ketamine infusion (LDKI) decreases narcotic use • does LDKI impact pulmonary complications, readmission, or hospital length of stay Participants will receive usual standard of care with up to 48 hours of LDKI or placebo. If there is a comparison group: Researchers will compare infusion of a saline infusion to LDKI to see if LDKI decreases need for narcotic analgesics use.

Interventions

  • DRUG Ketamine 1 Mg/mL-NaCl 0.9% Intravenous Solution

Study Locations (1)

Minnesota

  • North Memorial Health Hospital - Robbinsdale

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-10-01
Est. Completion 2023-06-26
Phase Phase 4

Sponsor

North Memorial Health Care

1 total trials

What the Registry Record Tells You About NCT06236113

The ClinicalTrials.gov registry entry for NCT06236113 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Memorial Health Care, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Blunt Injury of Thorax appearing as the primary indexed condition, and to 1 intervention - of which Ketamine 1 Mg/mL-NaCl 0.9% Intravenous Solution is the first listed.

NCT06236113 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06236113 about?

NCT06236113 is a clinical study titled "Low Dose Ketamine for Blunt Thoracic Trauma". The goal of this Randomized controlled double-blinded trial is to compare the addition of a ketamine infusion to placebo, when added to standard care in adult blunt trauma patients with multiple rib fractures. The main question it aims to answer are: • addition of low dose ketamine infusion (LDKI) d...

What is the current status of trial NCT06236113?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2021-10-01. Estimated completion is 2023-06-26.

What conditions does trial NCT06236113 study?

This clinical trial studies the following conditions: Blunt Injury of Thorax, Multiple Rib Fractures, Involving Three Ribs.

What interventions are being tested in trial NCT06236113?

The interventions under investigation include: Ketamine 1 Mg/mL-NaCl 0.9% Intravenous Solution (DRUG).

Who is sponsoring clinical trial NCT06236113?

This trial is sponsored by North Memorial Health Care, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06236113 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.